Elekta AB (publ) (STO:EKTA.B)
Sweden · Delayed Price · Currency is SEK 53.80
+0.10 (0.19%)
Aug 14, 2026, 5:29 PM CET
Elekta AB Market Cap
Elekta AB has a market cap or net worth of 20.56 billion as of August 14, 2026. Its market cap has increased by 14.08% in one year.
Market Cap
20.56B
Enterprise Value
24.75B
Revenue
16.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
53.80
ChartMarket Cap Chart
Since September 4, 1997, Elekta AB's market cap has increased from 1.51B to 20.56B, an increase of 1,264.60%. That is a compound annual growth rate of 9.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 20.56B | -5.20% |
| Dec 30, 2025 | 21.68B | -7.20% |
| Dec 30, 2024 | 23.36B | -25.72% |
| Dec 29, 2023 | 31.45B | 31.08% |
| Dec 30, 2022 | 23.99B | -45.18% |
| Dec 30, 2021 | 43.77B | 3.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 65.34B |
| Sectra AB | 53.64B |
| Nolato AB | 13.52B |
| Vitrolife AB | 12.44B |
| Xvivo Perfusion AB | 9.68B |
| MedCap AB | 8.18B |
| CellaVision AB | 3.63B |
| C-Rad AB | 1.22B |